Interestingly, a genome-wide association study implicated C1QL1 as a candidate gene associated with total body fat mass [24], indicating that C1QL1 is a potential new therapy for the aetiology of osteoporosis and obesity. The gene discussed is C1QL1; the disease is obesity disorder.